AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 58 filers reported holding AKERO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,812,538 | +44.9% | 1,103,306 | +33.8% | 0.01% | +40.0% |
| Q2 2023 | $38,505,584 | +51.1% | 824,707 | +23.8% | 0.01% | +66.7% |
| Q1 2023 | $25,478,380 | +73305.7% | 665,927 | +5.1% | 0.00% | -40.0% |
| Q4 2022 | $34,709 | -99.8% | 633,380 | +21.0% | 0.01% | +66.7% |
| Q3 2022 | $17,817,000 | +302.9% | 523,289 | +11.8% | 0.00% | +200.0% |
| Q2 2022 | $4,422,000 | -29.7% | 467,985 | +5.5% | 0.00% | 0.0% |
| Q1 2022 | $6,292,000 | -28.6% | 443,473 | +6.4% | 0.00% | 0.0% |
| Q4 2021 | $8,812,000 | +4.4% | 416,681 | +10.3% | 0.00% | 0.0% |
| Q3 2021 | $8,441,000 | -6.2% | 377,693 | +4.2% | 0.00% | 0.0% |
| Q2 2021 | $8,995,000 | +17.2% | 362,578 | +37.1% | 0.00% | 0.0% |
| Q1 2021 | $7,672,000 | +23.1% | 264,483 | +9.4% | 0.00% | 0.0% |
| Q4 2020 | $6,234,000 | -13.4% | 241,662 | +3.3% | 0.00% | 0.0% |
| Q3 2020 | $7,200,000 | +106.5% | 233,870 | +67.1% | 0.00% | 0.0% |
| Q2 2020 | $3,487,000 | +44.4% | 139,967 | +22.9% | 0.00% | 0.0% |
| Q1 2020 | $2,414,000 | -31.3% | 113,907 | -28.1% | 0.00% | – |
| Q4 2019 | $3,516,000 | +107.4% | 158,488 | +112.6% | 0.00% | – |
| Q3 2019 | $1,695,000 | – | 74,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $169,134,000 | 18.83% |
| venBio Partners LLC | 2,444,311 | $70,909,000 | 6.74% |
| Versant Venture Management, LLC | 617,727 | $17,920,000 | 3.49% |
| Redmile Group, LLC | 2,513,746 | $72,924,000 | 1.03% |
| Boxer Capital, LLC | 831,495 | $24,122,000 | 0.82% |
| Integral Health Asset Management, LLC | 85,000 | $2,466,000 | 0.70% |
| Vivo Capital, LLC | 673,280 | $19,532,000 | 0.69% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 32,000 | $928,000 | 0.51% |
| Cormorant Asset Management, LP | 742,549 | $21,541,000 | 0.48% |
| HHLR ADVISORS, LTD. | 1,656,673 | $48,060,000 | 0.48% |